Carlotta Antoniotti - Dipartimento di Oncologia, dei Trapianti e Delle Nuove Tecnologie, Azienda Ospedaliero-Universitaria Pisana

基本信息

Career Trajectory

Bio

Opera presso il Polo Oncologico dell’Azienda Ospedaliero-Universitaria di Pisa nel gruppo di ricerca del Prof. Falcone. Ha ricevuto il premio ”Coquer Cancer Foundation Merit Award 2016”, al meeting dell’ASCO (American Society Of Clinical Oncology) tenuto a Chicago, appuntamento annuale più importante sull’oncologia dove vengono accolti e premiati i migliori oncologi di tutto il mondo. E’ candidata al Premio Galilei Giovani del prossimo anno.

Research Interests

Papers共 199 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Liver Metastases Do Not Predict Resistance to the Addition of Atezolizumab to First-Line FOLFOXIRI Plus Bevacizumab in Proficient MMR Metastatic Colorectal Cancer: a Secondary Analysis of the AtezoTRIBE Study

C Antoniotti,M Carullo, D Rossini,F Pietrantonio,L Salvatore,S Lonardi,S Tamberi, C Sciortino,V Conca,M A Calegari,P Ciracì,E Tamburini,F Bergamo, C Boccaccio,A Passardi,G Ritorto,C Ugolini,G Aprile,J Galon,C Cremolini

ESMO openno. 2 (2025): 104135-104135

Cited0Views0WOSBibtex

Prognostic Impact of Depth of Response and Early Tumour Shrinkage in Patients with BRAFV600E-mutated Metastatic Colorectal Cancer Treated with Targeted Therapy

Guglielmo Vetere,Marco Maria Germani,Carlotta Antoniotti,Lisa Salvatore,Filippo Pietrantonio,Sara Lonardi,Maria Bensi,Filippo Ghelardi,Maria Alessandra Calegari,Rossana Intini, Alessandro Minelli,Francesco Giulio Sullo,Chiara Boccaccio,Ada Taravella,Alberto Puccini,Daniele Lavacchi, Laura Noto,Massimiliano Salati,Mario Scartozzi,Chiara Cremolini

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2025)

Cited0Views0WOSBibtex

A Constitutive Interferon-High Immunophenotype Defines Response to Immunotherapy in Colorectal Cancer

Amelia Acha-Sagredo, Pietro Andrei, Kalum Clayton, Emma Taggart,Carlotta Antoniotti, Chloé A. Woodman, Hassnae Afrache, Constance Fourny, Maria Armero, Hafsa Kaja Moinudeen,Mary Green, Nisha Bhardwaj, Anna Mikolajczak, Maria Rodriguez-Lopez, Marg Crawford, Emma Connick, Steven Lim,Philip Hobson, Josep Linares, Ekaterina Ignatova

Cancer cell（2025）

Cited0Views0WOSBibtex

Exploring the Prognostic and Predictive Impact of Genomic Loss of Heterozygosity and Homologous Recombination Deficiency Alterations in Patients with Metastatic Colorectal Cancer

Roberto Moretto, Marco Maria Germani, Martina Carullo, Veronica Conca, Alessandro Minelli,Mirella Giordano,Rossella Bruno,Daniele Rossini, Eleonora Gusmaroli, Maria Caterina De Grandis,Carlotta Antoniotti,Lisa Salvatore,Alessandro Passardi,Stefano Tamberi,Mario Scartozzi,Filippo Pietrantonio,Sara Lonardi,Clara Ugolini,Gianluca Masi,Chiara Cremolini

JCO precision oncology (2025): e2400567-e2400567

Cited0Views0WOSBibtex

The Relative Dose Intensity of First-Line FOLFOXIRI and FOLFOX/FOLFIRI Both in Combination with Bevacizumab Affects Prognosis of Metastatic Colorectal Cancer Patients: A Pooled Analysis of TRIBE and TRIBE2 Studies

R Moretto, D Rossini, Mariam Grazia Polito,Carlotta Antoniotti, Rossana Intini, Veronica Conca, Paola Andena, Martina Carullo,Lisa Salvatore, Marco Maria Germani,Francesca Bergamo,Alessandro Passardi, Paolo Ciracì,Emiliano Tamburini, Chiara Boccaccio,Alberto Zaniboni,Gianluca Masi,Filippo Pietrantonio,Sara Lonardi, C Cremolini

European journal of cancer (Oxford, England 1990) (2025): 115470-115470

Cited0Views0WOSBibtex

Trifluridine/tipiracil Plus Capecitabine and Bevacizumab As Upfront Treatment for Metastatic Colorectal Cancer: Results of the Phase 1 TriComB Study

Paolo Cirac,Veronica Conca,Roberto Moretto,Carlotta Antoniotti,Margherita Ambrosini,Sabina Murgioni,Giovanni Gori, Alessandra Russo,Francesca Bergamo,Giovanni Randon, Vittorio Studiale,Elisabetta Fini,Federica Marmorino,Beatrice Borelli,Marco Maria Germani,Guglielmo Vetere,Martina Carullo,Chiara Boccaccio,Gianluca Masi,Chiara Cremolini

Annals of Oncology (2024): S25-S26

Cited0Views0Bibtex

506O Evaluation of Risk of Disease Progression in First-Line Therapy of Unresected Metastatic Colorectal Cancer to Guide Intervals of Radiological Assessment: an Analysis of Eleven Randomized Trials by AIO and GONO

M.M. Germani,V. Heinemann,D. Rossini,L. Fischer von Weikersthal,F. Morano, K. Heinrich,A. Stahler,F. Bergamo, F. Kaiser,T. Decker,L. Salvatore, L. Weiss, A. Russo, M. Fuchs,A.A. Prete,C. Antoniotti,G. Masi, S. Stintzing,C. Cremolini,D.P. Modest

Annals of Oncology (2024): S430-S431

Cited0Views0Bibtex

Use of Circulating Tumor DNA (ctdna) to Affect the Adjuvant or Post-Adjuvant Treatment of Patients with Stage III and High-Risk Stage II Resected Colon Cancer: the ERASE-CRC Project by GONO

Veronica Conca,Guglielmo Vetere,Roberto Moretto,Sara Lonardi,Carlotta Antoniotti,Marco Maria Germani,Filippo Pietrantonio, Alessandro Bittoni,Martina Carullo,Lisa Salvatore,Alessandra Boccaccino,Monica Ronzoni,Gianmarco Ricagno,Ilaria Toma,Samanta Cupini,Tiziana Pia Latiano,Giuseppina Arcangeli,Gianluca Masi,Matteo Fassan,Chiara Cremolini

Journal of Clinical Oncologyno. 16_suppl (2024): TPS3644-TPS3644

Cited0Views0Bibtex

Late-line Options for Patients with Metastatic Colorectal Cancer: a Review and Evidence-Based Algorithm

Paolo Ciracì, Vittorio Studiale,Ada Taravella,Carlotta Antoniotti,Chiara Cremolini

Nature Reviews Clinical Oncologyno. 1 (2024): 28-45

Cited0Views0WOSNATUREBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn